Literature DB >> 19429985

Histopathology of naturally transmitted "rat respiratory virus": progression of lesions and proposed diagnostic criteria.

T M Albers1, M A Simon, C B Clifford.   

Abstract

Rat respiratory virus (RRV) is the working name for a novel respiratory pathogen of laboratory rats in North America, Europe, and Asia. Although the agent has not been definitively identified, evidence supports a viral etiology. Because no serologic or molecular assays for RRV are available, diagnosis depends on histopathologic evaluation of the lung. We introduced 104 Wistar Han rats, free of known pathogens and of RRV-associated lesions, into a rat production colony positive for RRV-type lesions, but free of other histologic, serologic, or microbiologic evidence of infectious disease. Lungs of 8 of the naïve rats were examined grossly and microscopically each week, weeks 0-13. Irregular gray-white lesions suggestive of interstitial pneumonia were grossly evident from weeks 6 through 13. Primary histopathologic evaluation of all lungs by one pathologist found multifocal, lymphohistiocytic interstitial pneumonia or prominent perivascular lymphoid cuffing from weeks 5 through 13. Based on results of the initial evaluation, diagnostic criteria for RRV infection (i.e., changes seen only after exposure to the RRV-positive colony) were tentatively selected and used by 2 other pathologists to classify each lung as RRV positive, RRV equivocal, or RRV negative. The secondary evaluation found 95% concordance in RRV diagnosis between pathologists, and correlated well with the initial evaluation, thus confirming the consistency of the criteria. These data show that RRV-naïve rats introduced into an RRV-endemic colony develop equivocal microscopic lesions of RRV by 5 weeks of exposure, and positive diagnostic lesions by 7 weeks. Interstitial pneumonia becomes grossly evident after 6 weeks of exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429985     DOI: 10.1354/vp.08-VP-0330-C-FL

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  6 in total

1.  Proceedings of the 2013 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Michael C Boyle; Molly H Boyle; Michelle C Cora; Torrie A Crabbs; Connie A Cummings; Margarita M Gruebbel; Crystal L Johnson; David E Malarkey; Elizabeth F McInnes; Thomas Nolte; Cynthia C Shackelford; Jerrold M Ward
Journal:  Toxicol Pathol       Date:  2013-12-13       Impact factor: 1.902

2.  Pneumocystis carinii infection causes lung lesions historically attributed to rat respiratory virus.

Authors:  Robert S Livingston; Cynthia L Besch-Williford; Matthew H Myles; Craig L Franklin; Marcus J Crim; Lela K Riley
Journal:  Comp Med       Date:  2011-02       Impact factor: 0.982

3.  Molecular detection of Pneumocystis in the lungs of cats.

Authors:  Patrizia Danesi; Michela Corrò; Christian Falcaro; Antonio Carminato; Tommaso Furlanello; Monia Cocchi; Mark B Krockenberger; Wieland Meyer; Gioia Capelli; Richard Malik
Journal:  Med Mycol       Date:  2019-10-01       Impact factor: 4.076

4.  Prevalence of viral, bacterial and parasitological diseases in rats and mice used in research environments in Australasia over a 5-y period.

Authors:  Elizabeth F McInnes; Lorna Rasmussen; Peony Fung; Amanda M Auld; Luisana Alvarez; David A Lawrence; Morgan E Quinn; Tammy D Utteridge; Gloria M del Fierro; Bianca A Vassallo; Robert Stevenson
Journal:  Lab Anim (NY)       Date:  2011-10-20       Impact factor: 12.625

5.  Interstitial pneumonia in immunocompetent laboratory rats caused by natural infection with Pneumocystis carinii.

Authors:  Masahiko Yasuda; Ritsuki Uchida; Yoko Kamai; Hanako Morita; Mai Tanaka; Tomoko Ishida; Misa Mochizuki; Masafumi Yamamoto; Nobuhito Hayashimoto; Kenji Kawai
Journal:  Exp Anim       Date:  2021-09-13

6.  Histopathology of Pneumocystis carinii pneumonia in immunocompetent laboratory rats.

Authors:  Hyun-Soo Kim; Sung-Im DO; Youn Wha Kim
Journal:  Exp Ther Med       Date:  2014-05-26       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.